Pluripotent stem cell-derived epithelium misidentified as brain microvascular endothelium requires ETS factors to acquire vascular fate.
Pluripotent stem cell-derived epithelium misidentified as brain microvascular endothelium requires ETS factors to acquire vascular fate.
复制标题
DOI:
10.1073/pnas.2016950118
复制
发表时间:
2021-02-23
影响因子:
11.1
通讯作者:
Lis R
中科院分区:
文献类型:
--
作者:
Lu TM;Houghton S;Magdeldin T;Durán JGB;Minotti AP;Snead A;Sproul A;Nguyen DT;Xiang J;Fine HA;Rosenwaks Z;Studer L;Rafii S;Agalliu D;Redmond D;Lis R
Human PSC-derived iBMECs have been generated to study disease mechanisms and drug development for neurological disorders. However, their full transcriptomic characterization is unclear, which could result in inaccurate physiological studies and development of treatments with ineffective clinical outcomes. Utilizing a comprehensive transcriptomic metaanalysis validated by physiological studies, we find that many current protocols used to generate iBMECs produce a homogenous epithelial cell population. Overexpression of ETS transcription factors reprogram these cells into phenotypic endothelial cells (rECs) which recapitulate certain vascular functions, albeit lacking expression of some organotypic transporter genes and high electrical resistance in vitro. Nevertheless, they represent a crucial step toward the generation of an in vitromodel suitable for physiological and pharmaceutical studies of the blood–brain barrier. Cells derived from pluripotent sources in vitro must resemble those found in vivo as closely as possible at both transcriptional and functional levels in order to be a useful tool for studying diseases and developing therapeutics. Recently, differentiation of human pluripotent stem cells (hPSCs) into brain microvascular endothelial cells (ECs) with blood–brain barrier (BBB)-like properties has been reported. These cells have since been used as a robust in vitro BBB model for drug delivery and mechanistic understanding of neurological diseases. However, the precise cellular identity of these induced brain microvascular endothelial cells (iBMECs) has not been well described. Employing a comprehensive transcriptomic metaanalysis of previously published hPSC-derived cells validated by physiological assays, we demonstrate that iBMECs lack functional attributes of ECs since they are deficient in vascular lineage genes while expressing clusters of genes related to the neuroectodermal epithelial lineage (Epi-iBMEC). Overexpression of key endothelial ETS transcription factors (ETV2, ERG, and FLI1) reprograms Epi-iBMECs into authentic endothelial cells that are congruent with bona fide endothelium at both transcriptomic as well as some functional levels. This approach could eventually be used to develop a robust human BBB model in vitro that resembles the human brain EC in vivo for functional studies and drug discovery.
登录
查看更多内容
影响因子:
64.5
作者:
Ginsberg M;James D;Ding BS;Nolan D;Geng F;Butler JM;Schachterle W;Pulijaal VR;Mathew S;Chasen ST;Xiang J;Rosenwaks Z;Shido K;Elemento O;Rabbany SY;Rafii S
通讯作者:
Rafii S
影响因子:
4.6
作者:
Grifno, Gabrielle N.;Farrell, Alanna M.;Searson, Peter C.
通讯作者:
Searson, Peter C.
影响因子:
20.3
作者:
Hu, Kejin;Yu, Junying;Slukvin, Igor I.
通讯作者:
Slukvin, Igor I.
影响因子:
5.9
作者:
Faley, Shannon L.;Neal, Emma H.;Bellan, Leon M.
通讯作者:
Bellan, Leon M.
影响因子:
5.9
作者:
Appelt-Menzel A;Cubukova A;Günther K;Edenhofer F;Piontek J;Krause G;Stüber T;Walles H;Neuhaus W;Metzger M
通讯作者:
Metzger M